Submitted by Anonymous (not verified) on 22 January 2026 - 13:12
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 22, Status: Authorised